Table 1 Patient details and clinicopathological features
From: Inducing multiple antibodies to treat squamous cell esophageal carcinoma
Esophageal cancer | |
|---|---|
Number | 85 |
Gender | |
Male | 73 (85.9%) |
Female | 12 (14.1%) |
Mean age ± s.d. (years) | 68.2 ± 7.7 |
Age range (years) | 45–85 |
Depth of tumor invasion | |
T1 | 28 (32.9%) |
T2 | 8 (9.4%) |
T3 | 29 (34.1%) |
T4 | 20 (23.5%) |
Lymph node metastasis | |
Positive | 56 (65.9%) |
Negative | 29 (34.1%) |
Distant metastasis | |
Positive | 19 (22.4%) |
Negative | 66 (77.6%) |
TNM stage | |
I | 26 (30.6%) |
II | 7 (8.2%) |
III | 19 (22.4%) |
IV | 33 (38.8%) |